Annexon ANNX
NASDAQ ANNX
$4.87 +0.03 (+0.62%)
As of: Sep 4, 2026 · 3:59 PM EDT

Annexon (ANNX) Other Working Capital Changes (2019 - 2026)

Annexon (ANNX) posted quarterly Other Working Capital Changes of -$605000.0 for Q1 2026, down 2850.0% year-over-year from $22000.0 in Q1 2025, and down 137.25% quarter-over-quarter from -$255000.0 in Q4 2025.

Analysis

Annexon (ANNX) Other Working Capital Changes (2019 - 2026) Analysis & Trends

Annexon's Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$605000.0 for Q1 2026.

  • In Q1 2026, Other Working Capital Changes fell 2850.0% year-over-year to -$605000.0; the TTM figure through Mar 2026 stood at -$1.2 million (up 6.27% YoY), while the FY2025 annual figure was -$598000.0, down 299.33% from the prior year.
  • Other Working Capital Changes for Q1 2026 stood at -$605000.0, down from -$255000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $1.6 million in Q1 2024, with the low at -$2.8 million in Q2 2024.
  • The 5-year median for Other Working Capital Changes is -$255000.0 (2025), against an average of -$114294.1.
  • The sharpest annual moves came in 2024 and 2026: Other Working Capital Changes surged 570.0% in 2024, then plunged 2850.0% in 2026.
  • Annexon's Other Working Capital Changes stood at $259000.0 in 2022, then tumbled by 84.56% to $40000.0 in 2023, then soared by 570.0% to $268000.0 in 2024, then sank by 195.15% to -$255000.0 in 2025, then sank by 137.25% to -$605000.0 in 2026.
  • Business Quant data shows ANNX's Other Working Capital Changes at -$605000.0 in Q1 2026, -$255000.0 in Q4 2025, and $999000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Annexon 982.93 Mn 982.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -783,000.00
Jun 30, 2026 -783,000.00
Mar 31, 2026 -767,000.00
Mar 31, 2026 -767,000.00
Dec 31, 2025 -737,000.00
Dec 31, 2025 -737,000.00
Sep 30, 2025 -692,000.00
Sep 30, 2025 -692,000.00
Jun 30, 2025 -678,000.00
Jun 30, 2025 -678,000.00
Mar 31, 2025 -664,000.00
Mar 31, 2025 -664,000.00
Dec 31, 2024 -635,000.00
Dec 31, 2024 -635,000.00
Sep 30, 2024 -596,000.00
Sep 30, 2024 -596,000.00
Jun 30, 2024 -2.78 Mn
Jun 30, 2024 -2.78 Mn
Mar 31, 2024 1.63 Mn
Mar 31, 2024 1.63 Mn